Immunogenicity and Safety of High-Dose Trivalent Inactivated Influenza Vaccine Compared to Standard-Dose Vaccine in Children and Young Adults with Cancer or HIV Infection

BACKGROUND: Approaches to improve the immune response of immunocompromised patients to influenza vaccination are needed. METHODS: Children and young adults (3–21 years) with cancer or HIV infection were randomized to receive 2 doses of high-dose (HD) trivalent influenza vaccine (TIV) or of standard-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vaccine
Egile Nagusiak: Hakim, Hana, Allison, Kim J., Van de Velde, Lee-Ann, Tang, Li, Sun, Yilun, Flynn, Patricia M., McCullers, Jonathan A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4899146/
https://ncbi.nlm.nih.gov/pubmed/27129426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.04.053
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak